Global Bone and Musculoskeletal Allografts Market Overview

The Global Bone and Musculoskeletal Allografts market size is estimated to reach $3,298 million by 2026 growing at a CAGR of 4.1% over the forecast period of 2021-2026. Bone and Musculoskeletal allografts are implantable materials that promote osseous reconstruction, healing, and bone formation. Bone and Musculoskeletal allografts are used to repair skeletal defects and are increasingly being adopted as alternatives to bone autografts owing to their ability to enable structural restoration of the skeleton and also surfaces support bone formation through their successful principles, such as osteoinduction, osteoconduction, and osteogenesis. These allografts also provide structural stability in the absence of a bone in humans and are used to address the reconstructive needs of an increasing number of patients across the world. Major factors driving the growth of the Bone and Musculoskeletal Allografts market include growing advancements in the field of bioengineering and medical technologies, increasing awareness about the importance of allografts compared to autografts, and the rise in research and development activities to deliver advanced products to healthcare systems.

Report Coverage and Scope

The report “Global Bone and Musculoskeletal Allografts Market”, by Research Informatic covers an in-depth detailed analysis for the following segment which are covered under scope.

By Type

• Corticocancellous Allografts
• Massive Structural Allografts
• Osteoinductive Allografts

By Application

• Sport Surgery
• Spine
• Dental
• Reconstruction and Traumatology

By End User:

• Hospitals and Specialty Clinics
• Ambulatory Surgery Centers
• Others

Geography

• North America
• Europe
• APAC
• RoW

Key Takeaways from Global Bone and Musculoskeletal Allografts Market Report:

• Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units), and Value ($M) data given at country level – for types, end-use applications, and by different industry verticals.
• Understand the different dynamics influencing the market – key driving factors, challenges, and hidden opportunities.
• Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
• Analyze the sales and distribution channels across key geographies to improve top-line revenues.
• Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
• Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
• Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.

By type, market for corticocancellous allografts to grow at the highest CAGR during the forecast period

During the forecast period, the market for corticocancellous allografts is predicted to develop at the fastest rate of XX%. It also holds the largest share in 2020.  Corticocancellous fresh-frozen allografts are extensively being incorporated as a viable alternative to reconstruct an atrophied mandible in the posterior region, installation of implants, allowing for new bone formation, and prosthetic loading. Moreover, nonvascularized structural corticocancellous allografts performed with bone from the olecranon showed more benefits over bone from the iliac crest for the treatment of segmental bone defects of the phalanges.

By Application, Bone and Musculoskeletal Allografts market for spine applications to grow at the highest CAGR during the forecast period

During the projection period, the Bone and Musculoskeletal Allografts market for spine applications is predicted to develop at the fastest CAGR. Bone allografts are effectively being used in spinal surgeries for working as a bridge that allows the actual bone to grow through its surface and replace the donor bone with the natural bone. Moreover, Bone and Musculoskeletal allografts are well suited for reconstructive procedures and have excellent fusion rates.

North America to account for the largest market share during the forecast period

North America held largest share for the Global Bone and Musculoskeletal Allografts market in 2020 with global market share of XX%. The demand for Bone and Musculoskeletal Allografts in North America is growing owing to the increasing inclination towards minimally invasive procedures. Furthermore, the rise in the demand for orthopedic bone casting material and allografts among the geriatric population, and the growing prevalence of dental problems are propelling the key players in the region to develop advanced bone and musculoskeletal allografts.

Asia Pacific is set to be the fastest growing over the period 2021-2026. The major drivers for the rapid growth of the Bone and Musculoskeletal Allografts market in the Asia Pacific are the growing prevalence of osteoporosis, the rise in the adoption of bone allografts in orthopedic procedures, and the increase in the research and development activities to develop bone and musculoskeletal allografts.

Market Dynamics

Driver:  Growing demand for allografts in orthopedic procedures

The use of allografts is effectively becoming a vital option for orthopedic surgeons for the treatment of various musculoskeletal lesions, such as meniscal deficiency in the young athlete and osteochondral defects in the glenohumeral joint. Orthopedic surgeons across the world are incorporating allografts into their surgical practice for the treatment of osteoarthritic lesions and tumors. The key players are focusing on developing transplanted bone for surgical procedures to repair and rebuild damaged and diseased bones. The allografts are also being adopted to stimulate and speed up and the healing of bone and are placed around the fracture sites to help the surrounding bones to heal quicker. Researchers in developed nations are working on developing bone allografts that are used to provide structural support, decrease infection risk, and decrease the surgical time for orthopedic surgeries.

Challenge: High Cost of Bone and Musculoskeletal Allografts.

The cost of allografts varies considerably and the material used and complexity of the procedure are the two main factors influencing the cost of bone and musculoskeletal allografts. The cost of allografts varies between $400 and $1,200 when bone material comes from a cadaver, animal, and synthetic substance and the cost jumps to $2,000 and more if the bone material is harvested from own body. Moreover, many insurance providers are not covering dental bone allografts in most circumstances. In addition, if the allograft should be performed using the patient’s own bone, an anesthesiologist and orthopedic surgeon must be hired and the patient must be hospitalized to extract the bone, thereby increasing cost. The price range for this type of treatment is $2,500 to $3,500. During the projected period, the impact of this difficulty is predicted to be moderate.

Key Market Players

Key Players in Global Bone and Musculoskeletal Allografts Market consist of Zimmer Biomet (US), Lynch Biologics (US), Medtronic (Ireland), Stryker Corporation (US), Biomatlante (France), Royal Biologics LLC (US), Arthrex, Inc (US), Baxter International Inc. (US), Smith & Nephew (UK), Johnson and Johnson (US) among others.

Recent Developments:

• In January 2020, Royal Biologics LLC has launched MAGNUS, a DMSO-free cellular bone allograft for presenting solutions to cellular allograft technology as it utilizes cryoprotectants and to differentiate MAGNUS from various other technologies that are currently available in the market for enhancing the portfolio of orthobiologic solutions.

Chapter 1 Bone and Musculoskeletal Allografts Market Overview

1.1 Product Overview and Scope of Bone and Musculoskeletal Allografts

1.2 Bone and Musculoskeletal Allografts Market Segmentation By Type

1.2.1 Corticocancellous Allografts

1.2.2 Massive Structural Allografts

1.2.3 Osteoinductive Allografts

1.3 Bone and Musculoskeletal Allografts Market Segmentation by Application

1.3.1 Sport Surgery

1.3.2 Spine

1.3.3 Dental

1.3.4 Reconstruction and Traumatology

1.4 Bone and Musculoskeletal Allografts Market Segmentation by Regions

1.4.1 North America

1.4.2 China

1.4.3 Europe

1.4.4 Southeast Asia

1.4.5 Japan

1.4.6 India

1.5 Global Market Size (Value) of Bone and Musculoskeletal Allografts (2015-2027)

Chapter 2 Global Economic Impact on Bone and Musculoskeletal Allografts Industry

2.1 Global Macroeconomic Environment Analysis

2.1.1 Global Macroeconomic Analysis

2.1.2 Global Macroeconomic Environment Development Trend

2.2 Global Macroeconomic Environment Analysis by Regions

Chapter 3 Global Bone and Musculoskeletal Allografts Market Competition by Manufacturers

3.1 Global Bone and Musculoskeletal Allografts Production and Share by Manufacturers (2021 and 2021)

3.2 Global Bone and Musculoskeletal Allografts Revenue and Share by Manufacturers (2021 and 2021)

3.3 Global Bone and Musculoskeletal Allografts Average Price by Manufacturers (2021 and 2021)

3.4 Manufacturers Bone and Musculoskeletal Allografts Manufacturing Base Distribution, Production Area and Product Type

3.5 Bone and Musculoskeletal Allografts Market Competitive Situation and Trends

3.5.1 Bone and Musculoskeletal Allografts Market Concentration Rate

3.5.2 Bone and Musculoskeletal Allografts Market Share of Top 3 and Top 5 Manufacturers

3.5.3 Mergers & Acquisitions, Expansion

Chapter 4 Global Bone and Musculoskeletal Allografts Production, Revenue (Value) by Region (2015-2021)

4.1 Global Bone and Musculoskeletal Allografts Production by Region (2015-2021)

4.2 Global Bone and Musculoskeletal Allografts Production Market Share by Region (2015-2021)

4.3 Global Bone and Musculoskeletal Allografts Revenue (Value) and Market Share by Region (2015-2021)

4.4 Global Bone and Musculoskeletal Allografts Production, Revenue, Price and Gross Margin (2015-2021)

4.5 North America Bone and Musculoskeletal Allografts Production, Revenue, Price and Gross Margin (2015-2021)

4.6 Europe Bone and Musculoskeletal Allografts Production, Revenue, Price and Gross Margin (2015-2021)

4.7 China Bone and Musculoskeletal Allografts Production, Revenue, Price and Gross Margin (2015-2021)

4.8 Japan Bone and Musculoskeletal Allografts Production, Revenue, Price and Gross Margin (2015-2021)

4.9 Southeast Asia Bone and Musculoskeletal Allografts Production, Revenue, Price and Gross Margin (2015-2021)

4.10 India Bone and Musculoskeletal Allografts Production, Revenue, Price and Gross Margin (2015-2021)

Chapter 5 Global Bone and Musculoskeletal Allografts Supply (Production), Consumption, Export, Import by Regions (2015-2021)

5.1 Global Bone and Musculoskeletal Allografts Consumption by Regions (2015-2021)

5.2 North America Bone and Musculoskeletal Allografts Production, Consumption, Export, Import by Regions (2015-2021)

5.3 Europe Bone and Musculoskeletal Allografts Production, Consumption, Export, Import by Regions (2015-2021)

5.4 China Bone and Musculoskeletal Allografts Production, Consumption, Export, Import by Regions (2015-2021)

5.5 Japan Bone and Musculoskeletal Allografts Production, Consumption, Export, Import by Regions (2015-2021)

5.6 Southeast Asia Bone and Musculoskeletal Allografts Production, Consumption, Export, Import by Regions (2015-2021)

5.7 India Bone and Musculoskeletal Allografts Production, Consumption, Export, Import by Regions (2015-2021)

Chapter 6 Global Bone and Musculoskeletal Allografts Production, Revenue (Value), Price Trend by Type

6.1 Global Bone and Musculoskeletal Allografts Production and Market Share by Type (2015-2021)

6.2 Global Bone and Musculoskeletal Allografts Revenue and Market Share by Type (2015-2021)

6.3 Global Bone and Musculoskeletal Allografts Price by Type (2015-2021)

6.4 Global Bone and Musculoskeletal Allografts Production Growth by Type (2015-2021)

Chapter 7 Global Bone and Musculoskeletal Allografts Market Analysis by Application

7.1 Global Bone and Musculoskeletal Allografts Consumption and Market Share by Application (2015-2021)

7.2 Global Bone and Musculoskeletal Allografts Consumption Growth Rate by Application (2015-2021)

7.3 Market Drivers and Opportunities

7.3.1 Potential Applications

7.3.2 Emerging Markets/Countries

Chapter 8 Bone and Musculoskeletal Allografts Manufacturing Cost Analysis

8.1 Bone and Musculoskeletal Allografts Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labour Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of Bone and Musculoskeletal Allografts

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Bone and Musculoskeletal Allografts Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of Bone and Musculoskeletal Allografts Major Manufacturers in 2021

9.4 Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

Chapter 11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

Chapter 12 Global Bone and Musculoskeletal Allografts Market Forecast (2021-2027)

12.1 Global Bone and Musculoskeletal Allografts Production, Revenue Forecast (2021-2027)

12.2 Global Bone and Musculoskeletal Allografts Production, Consumption Forecast by Regions (2021-2027)

12.3 Global Bone and Musculoskeletal Allografts Production Forecast by Type (2021-2027)

12.4 Global Bone and Musculoskeletal Allografts Consumption Forecast by Application (2021-2027)

12.5 Bone and Musculoskeletal Allografts Price Forecast (2021-2027)

Chapter 13 Appendix